Fig. 1From: Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trialFlowchart of the randomized controlled trial. ITT, intention-to-treatBack to article page
